Page last updated: 2024-10-30

metformin and MELAS

metformin has been researched along with MELAS in 4 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"A 40-year-old man with sensorineural hearing loss and diabetes mellitus was hospitalized with acute-onset impaired consciousness and clumsiness in his left hand."5.91Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes. ( Ishiguchi, H; Ito, H; Murakami, K; Sakamoto, K, 2023)
"A 40-year-old man with sensorineural hearing loss and diabetes mellitus was hospitalized with acute-onset impaired consciousness and clumsiness in his left hand."1.91Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes. ( Ishiguchi, H; Ito, H; Murakami, K; Sakamoto, K, 2023)
"m."1.72Neurological manifestations in m.3243A>G-related disease triggered by metformin. ( Chan, KW; Ching, CK; Lam, SF; Lee, HH; Li, JK; Sheng, B; Tam, HV; Tong, HF; Tong, TT, 2022)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Tong, HF1
Lee, HH1
Tong, TT1
Lam, SF1
Sheng, B1
Chan, KW1
Li, JK1
Tam, HV1
Ching, CK1
Murakami, K1
Sakamoto, K1
Ishiguchi, H1
Ito, H1
Kim, NH1
Siddiqui, M1
Vogel, J1
Trebach, J1
Ghazali, D1
Burke, DJ1
Mahonski, SG1
Hoffman, RS1

Other Studies

4 other studies available for metformin and MELAS

ArticleYear
Neurological manifestations in m.3243A>G-related disease triggered by metformin.
    Journal of diabetes and its complications, 2022, Volume: 36, Issue:3

    Topics: Deafness; Diabetes Mellitus; DNA, Mitochondrial; Hearing Loss; Humans; MELAS Syndrome; Metformin

2022
Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2023, Volume: 32, Issue:5

    Topics: Acidosis, Lactic; Adult; Hearing Loss, Sensorineural; Humans; Male; MELAS Syndrome; Metformin; Strok

2023
MELAS Syndrome and MIDD Unmasked by Metformin Use: A Case Report.
    Annals of internal medicine, 2021, Volume: 174, Issue:1

    Topics: Adult; Brain; Deafness; Diabetes Mellitus, Type 2; Diagnosis, Differential; Electroencephalography;

2021
Initiation of metformin in MELAS patient-a dangerous combination.
    Clinical toxicology (Philadelphia, Pa.), 2022, Volume: 60, Issue:3

    Topics: Cognition; Diabetes Mellitus, Type 2; Humans; MELAS Syndrome; Metformin

2022